Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (241-250 of 527) with videos related to

Pageof 53
Sort By:
The Kaohsiung Journal of Medical Sciences|September 15, 2012
Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese populationMeng-Hsuan Hsieh, Wen-Yi Lin, Hsu-Han Chien, et al.
Gut|September 8, 2006
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis CMing-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 29, 2007
Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensationChia-Yen Dai, Ming-Lung Yu, Ming-Yen Hsieh, et al.
The Kaohsiung Journal of Medical Sciences|October 21, 2017
The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agentsJee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
Pegylated interferon plus ribavirin therapy improves pancreatic β-cell function in chronic hepatitis C patientsJee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, et al.
The Kaohsiung Journal of Medical Sciences|August 17, 2017
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patientsChing-I Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Oncotarget|March 20, 2018
Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis CMing-Lun Yeh, Ching-I Huang, Chung-Feng Huang, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 8, 2008
Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in TaiwanChung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, et al.
Clinical Chemistry and Laboratory Medicine|July 9, 2008
Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infectionsJee-Fu Huang, Chia-Yen Dai, Ya-Yun Lin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|October 23, 2008
Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis CChia-Yen Dai, Wan-Long Chuang, Li-Po Lee, et al.
Pageof 53

Showing results (241-250 of 527) with videos related to

Sort By:
Pageof 53
The Kaohsiung Journal of Medical Sciences|September 15, 2012
Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese populationMeng-Hsuan Hsieh, Wen-Yi Lin, Hsu-Han Chien, et al.
Gut|September 8, 2006
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis CMing-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 29, 2007
Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensationChia-Yen Dai, Ming-Lung Yu, Ming-Yen Hsieh, et al.
The Kaohsiung Journal of Medical Sciences|October 21, 2017
The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agentsJee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
Pegylated interferon plus ribavirin therapy improves pancreatic β-cell function in chronic hepatitis C patientsJee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, et al.
The Kaohsiung Journal of Medical Sciences|August 17, 2017
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patientsChing-I Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Oncotarget|March 20, 2018
Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis CMing-Lun Yeh, Ching-I Huang, Chung-Feng Huang, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 8, 2008
Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in TaiwanChung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, et al.
Clinical Chemistry and Laboratory Medicine|July 9, 2008
Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infectionsJee-Fu Huang, Chia-Yen Dai, Ya-Yun Lin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|October 23, 2008
Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis CChia-Yen Dai, Wan-Long Chuang, Li-Po Lee, et al.
Pageof 53